Turnover Studies on Cardiac Natriuretic Peptides: Methodological,Pathophysiological and Therapeutical Considerations.
Journal:
Current Drug Metabolism
Volume:
1
Page:
85-105
Author(s):
Aldo Clerico, Giorgio Iervasi and Alessandro Pilo
Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
11-31
Author(s):
W. Jelkmann
Transcription Factors as Potential Targets for Therapeutic Drugs
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
57-61
Author(s):
David S. Latchman
Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
83-106
Author(s):
A. Zlobin, M. Jang and L. Miele
Recent Developments in Receptor-Selective Retinoids
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
919-931
Author(s):
Sunil Nagpal and Roshantha A.S. Chandraratna
Mechanisms for the Selective Actions of Vitamin D Analogues
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
701-716
Author(s):
Alex J. Brown
Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
717-732
Author(s):
Gert-Jan C.M. van den Bemd, Huibert A.P. Pols and Johannes P.T.M. van Leeuwen
Biological Activity In Vitro of Side-Chain Modified Analogues of Calcitriol
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
755-765
Author(s):
A. Opolski, J. Wietrzyk, A. Siwinska, E. Marcinkowska, A. Chrobak, A. Kutner and C. Radzikowski
Gene Vectors for Cytokine Expression In Vivo
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
613-632
Author(s):
M. M. Hitt and J. Gauldie
Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
417-439
Author(s):
Maralea Gourley and John S. Williamson